Dental Care for Veterans Act
Summary
The Dental Care for Veterans Act (HR210) expands VA dental eligibility to all enrolled veterans, adding an estimated $5-10B in annual VA procurement of dental supplies, equipment, and services. Pure-play dental suppliers HSIC and XRAY are the strongest structural beneficiaries. The bill is in committee with 94 cosponsors—strong momentum but still mid-stage. No direct funding is authorized; actual appropriations will be determined separately.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The bill expands VA dental eligibility to all enrolled veterans, creating an estimated $5-10B annual TAM expansion
- 2.Pure-play dental suppliers HSIC and XRAY are the strongest structural beneficiaries with direct revenue exposure
- 3.Health insurers (UNH, CVS, HUM) face lower confidence upside contingent on VA contracting decisions
- 4.The bill has strong momentum (94 cosponsors, subcommittee cleared) but requires full committee markup and appropriations
- 5.No executive orders directly amplify or conflict with this bill; the mental health EO is unrelated
Market Implications
Dental supply and equipment stocks ($HSIC, $XRAY) are the most directly leveraged to this legislation. HSIC at $76.12 has already shown a +5.58% 30-day gain—investors appear to be pricing in some bill momentum. XRAY at $11.78 is near its 52-week low and offers asymmetric upside if the bill advances. Both trade at depressed multiples relative to historical averages. Health insurers ( at $366.77, $CVS at $80.98, at $229.72) have rallied sharply on non-dental factors, but the dental bill adds a free option on additional government business. The near-term catalyst is full committee markup—expect increased attention on tickers HSIC and XRAY if the bill progresses.
Full Analysis
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Improving Seniors’ Timely Access to Care Act of 2025
Consolidated Appropriations Act, 2026
I CAN Act
Putting Patients First Healthcare Freedom Act
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Living Donor Protection Act of 2025
Puerto Rico Affordable Care Act of 2025
TRIWEST HEALTHCARE ALLIANCE CORP: $820M Department of Veterans Affairs Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.